Blog
Jasper Reports Wider Loss in Fiscal Q2
Jasper Therapeutics (NASDAQ:JSPR), a clinical-stage biotechnology company focused on therapies for mast cell-driven diseases like chronic urticaria, released its second quarter 2025 financial
Boston Omaha Posts 4% Sales Gain
Boston Omaha (NYSE:BOC), a diversified holding company with businesses in outdoor advertising, broadband services, and insurance, posted its second quarter 2025 results on Aug. 13, 2025. Revenue
Boxlight Sales Drop 20 Percent
Boxlight (NASDAQ:BOXL), an education technology company specializing in interactive classroom solutions and digital displays, reported its financial results for the second quarter of fiscal 2025 on
Hyperfine HYPR Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Aug. 13, 2025 at 4:30 p.m. ET
President and Chief Executive Officer — Maria Sainz
Source Fool.com
HeartBeam Cuts Costs Awaits FDA Decision
HeartBeam (NASDAQ:BEAT) reported its Q2 2025 results on July 16, 2025, reaffirming key regulatory and commercial milestones and announcing a 23% sequential decrease in cash burn to $3.4 million. The
Why Novo Nordisk Stock Topped the Market Today
Novo Nordisk (NYSE: NVO) is quite the divisive stock among both investors and analysts these days. Although its high-profile obesity drug Wegovy has been a raging success, the company is being
HeartBeam (BEAT) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, August 13, 2025 at 4:30 p.m. ET
Chief Executive Officer — Rob Eno
Source Fool.com
Xos Reports Record Q2 Revenue Growth
Xos (NASDAQ:XOS), a manufacturer of battery-electric commercial vehicles, reported its second quarter earnings on August 13, 2025. The release was notable for record GAAP revenue of $18.4 million
Crescent Capital BDC Earnings Miss
Crescent Capital BDC (NASDAQ:CCAP), a business development company focused on lending to middle-market companies, released its second quarter 2025 earnings results on August 13, 2025. The most
Aqua Metals AQMS Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Aug. 13, 2025 at 4:30 p.m. ET
Chief Executive Officer — Steve Cotton
Source Fool.com
Expion360 Q2 Revenue Jumps 134%
Expion360(NASDAQ:XPON) reported second quarter 2025 results on Aug. 13, 2025, with GAAP revenue up 134% year-over-year to $3 million and net loss improving 38% to $1.4 million. The company achieved
Aqua Metals Hits Lithium Purity Record
Aqua Metals(NASDAQ:AQMS) reported fiscal second quarter 2025 results for the period ended June 30, 2025, on Aug. 13, 2025, highlighting record lithium purity, a strengthened balance sheet, and
Codexis Revenue Jumps 91 Percent in Q2
Codexis (NASDAQ:CDXS), a biotechnology company specializing in enzyme engineering for pharmaceutical manufacturing, released its second quarter 2025 results on August 13, 2025. The headline news was
Xos Sets Q2 Revenue and Delivery Records
Xos(NASDAQ:XOS) reported second-quarter 2025 results on August 13, 2025, posting record quarterly GAAP revenue of $18.4 million on 135 units delivered and achieving its lowest operating loss as a
Xos (XOS) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Aug. 13, 2025 at 4:30 p.m. ET
Chief Executive Officer — Dakota Semler
Source Fool.com
CMCT Leasing Surges as NOI Drops in Q2
Creative Media & Community Trust (NASDAQ:CMCT) reported fiscal Q2 2025 results on Aug. 12, 2025, highlighting a core funds from operations (FFO) loss of $7.2 million and a year-over-year increase of
Longeveron Posts 32% Revenue Drop in Q2
Longeveron (NASDAQ:LGVN), a clinical-stage biotechnology firm focused on stem cell therapies for rare and aging-related diseases, released its second quarter earnings on August 13, 2025.
The most
Tenon Medical Revenue Falls 37 Percent
Tenon Medical(NASDAQ:TNON) reported results for the fiscal second quarter ended June 30, 2025, on August 6, 2025, emphasizing the completed CyVantage acquisition, a 29% year-over-year drop in
Tenon Medical (TNON) Q2 2025 Earnings Transcript
Image source: The Motley Fool.
Aug. 13, 2025, at 4:30 p.m. ET
Chief Executive Officer — Steven Foster
Source Fool.com
IceCure Medical Advances FDA Review
IceCure Medical(NASDAQ:ICCM) reported second-quarter 2025 results on Aug. 13, 2025, with revenue declining year-over-year to $1.25 million from $1.75 million for the six months ended June 30, 2025
Barfresh Q2 Revenue Up 11 Percent
Barfresh Food Group (NASDAQ:BRFH) reported second quarter 2025 results on August 13, 2025, highlighting 11% year-over-year revenue growth to $1.6 million (GAAP) in Q2 FY2025 and milestone
Barfresh (BRFH) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Wednesday, August 13, 2025 at 4:30 p.m. ET
Chief Executive Officer — Riccardo Delle Coste
Source Fool.com
Forian Revenue Jumps 56 Percent in Q2
Forian (NASDAQ:FORA), a healthcare and life sciences data analytics provider, reported better-than-expected Q2 2025 results (GAAP), released on August 13, 2025. The company posted GAAP revenue of
Aardvark Therapeutics Reports Q2 Loss
Aardvark Therapeutics (NASDAQ:AARD), a clinical-stage biopharmaceutical company developing new treatments for rare and metabolic diseases, reported its financial results on August 13, 2025. The most
Red Robin Swings to Profit in Fiscal Q2
Red Robin Gourmet Burgers (NASDAQ:RRGB), a family-friendly, casual-dining chain known for gourmet burgers and bottomless sides, released its fiscal second quarter 2025 results on August 13, 2025